VillageMD – Talk Bio

Actionable Insights Powered by AI

Walgreens Takes $6 Billion Hit from VillageMD Investment Amid Strategic Review

1 year ago talkbio0Tagged Clinic, Cost Savings Plan, Investment Value Decline, Quarter 2, strategic review, VillageMD, Walgreens, Write-down

Walgreens, VillageMD, Quarter 2, $6 billion loss, Write-down, Investment Value Decline, Strategic Review, Cost Savings Plan, Underperforming Clinics Closure